Video: Interview With Ovid Therapeutics' Jeremy Levin
Executive Summary
The former Teva CEO now heads up neuroscience-focused Ovid. At BioPharm America, he discussed the trend of execs moving from large pharmas to smaller companies as well as the business strategy for Ovid.